Skip to main content
Clinical Trials/CTRI/2024/04/065924
CTRI/2024/04/065924Not yet recruitingPhase 1

Adjunct therapy with topical Recombinant DNA Polymerase in Dry eye disease - NI

Dr RP Centre Of Ophthalmic Sciences0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients more than 18 years of age with moderate to severe dry eye disease
  • Tear film breakup time less than or equal to seven seconds
  • Schirmers test less than or equal to 10mm for 5 min
  • OSDI Score more than equal to 13

Exclusion Criteria

  • Patients not consenting to follow up
  • Presence of active systemic or ocular infection
  • Allergic to any topical eye drops
  • Use of contact lens within last two weeks
  • Pregnant or lactating
  • Associated ocular inflammatory conditions
  • Any cognitive or psychiatric deficit that precludes consent or ability to perform
  • Hace active drug or alcohol dependance

Investigators

Sponsor
Dr RP Centre Of Ophthalmic Sciences

Similar Trials